First gene therapy trial aims to restore hearing in children

The aim of this clinical trial, which has just received approval in France, is to assess the safety and efficacy of a new gene therapy drug in children aged between 6 and 31 months with profound hearing loss.

Antibody fragment discovery could lead to much-needed treatment for light chain amyloidosis

In people with a rare condition called light chain amyloidosis, light chain proteins-;which are a component of antibodies-;mutate and build up in different organs.

July 10, 2024

ePRO vs eCOA: Understanding the nuances in clinical trials – Pharmaceutical Technology

Two such tools – electronic patient-reported outcomes (ePRO) and electronic clinical outcomes assessments (eCOA) – are often mentioned together. However, they serve distinct purposes and

May 1, 2024

Non-Hallucinogenic Trip Reports: Searching for the Tabernanthalog Tasters – Psychedelic Alpha

His Discord bio “Pioneering the evolution of intelligence through pharmacological means.” In his Discord posts he documented his experience on TBG in almost real-time. The

July 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.